Brian Solow, M.D., F.A.A.F.P.
Topics: Value-Based Pharmacy Contracting, Specialty Pharmacy, Medication Adherence, Medication Therapy Management, Medication Pipeline (future medications in development), Drug Safety, Prescription Medication Substance Abuse Prevention
Recent Speeches/Presentations: "Value-Based Pharmacy Contracting: The Future for Specialty Medicines"
Brian Solow serves as chief medical officer, Optum Life Sciences, a segment of Optum and UnitedHealth Group. Optum Life Sciences helps pharmaceutical, biotechnology and medical device companies successfully address product development and commercialization challenges by delivering a full range of integrated solutions in the areas of strategic insight, value assessment, evidence development, alignment to commercial needs and launch support. Prior to his current position, Dr. Solow served as chief medical officer, OptumRx, which provides innovative pharmacy benefit management services and products to employer groups, union trusts, commercial, Medicare and other governmental health plans. Dr. Solow's primary responsibility at OptumRx was the coordination of clinical activities related to the development, enhancement and implementation of clinical programs supporting formulary management for OptumRx clients.
Prior to joining the clinical team at Optum, Dr. Solow was an active member of a physician-owned medical group, maintaining a full-time practice while simultaneously holding various management roles within the group. He has served as a member of national pharmacy and therapeutics committees for leading managed care organizations and pharmacy benefit management firms. Dr. Solow is a well-known national and international speaker on a variety of topics relating to pharmacy management.
Dr. Solow holds an active appointment as clinical professor at the University of California, San Francisco, School of Pharmacy, and an appointment at the University of Southern California School of Pharmacy. He received the Family Medicine department award from the University of California, Irvine School of Medicine, for distinguished practice and teaching.
Dr. Solow is a fellow of the American Academy of Family Physicians, a member of the U.S. Pharmacopeia Medicare Model Guideline Expert Panel advisory committee, and he serves on FDA advisory panels. He is also active in ISPOR, serving as the U.S. representative for the Health Technology Assessment Council. The Orange County Medical Association has recognized him several times as a Physician of Excellence.